NEXIUM is the only brand in its class with Preferred formulary status at all 3 of the nation’s largest prescription benefit providers†1
√=Tier 1 or 2; X = Tier 3, as defined by Caremark, Express Scripts, and Medco Health.
Prescription approval rates do not imply comparable efficacy, safety, or FDA-approved indications.
†Individual benefit design may vary.
‡Caremark Formularies (Primary and Performance).
§Express National Preferred and Prime Formularies.
║Medco Standard Formularies (Primary Prescriptions® and Rx SelectionsTM).
Formulary comparisons do not imply comparable efficacy, safety, or FDA-approved indications.
AstraZeneca does not endorse any individual plan or provider.
Aciphex is a registered trademark of Eisai Co., Ltd. Zegerid is a registered trademark of Santarus, Inc. Dexilant is a trademark of Takeda Pharmaceuticals North America, Inc., and is used under license by Takeda Pharmaceuticals America, Inc. Fingertip Formulary is a registered trademark of Fingertip Formulary, LLC. Express Scripts is a registered trademark of Express Scripts, Inc. Preferred Prescriptions is a registered trademark and Rx Selections is a trademark of Medco Health Solutions, Inc.
1. Data on file, #2412802. Fingertip Formulary® Database as of February 5, 2013.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.